Related references
Note: Only part of the references are listed.The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
Yuan-Chen Cui et al.
FRONTIERS IN PHYSIOLOGY (2018)
The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway
Qian Zhang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
Hong Chang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Mitochondrial dynamics, mitophagy and cardiovascular disease
Cesar Vasquez-Trincado et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway
Yong Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Mitochondrial dynamism and heart disease: changing shape and shaping change
Gerald W. Dorn
EMBO MOLECULAR MEDICINE (2015)
Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases
Stephen L. Archer
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PGC1α and mitochondrial metabolism - emerging concepts and relevance in ageing and neurodegenerative disorders
Shane Austin et al.
JOURNAL OF CELL SCIENCE (2012)
Analysis on outcome of 5284 patients with coronary artery disease: The role of integrative medicine
Zhu-ye Gao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Preferential Oxidation of Triacylglyceride-Derived Fatty Acids in Heart Is Augmented by the Nuclear Receptor PPARα
Natasha H. Banke et al.
CIRCULATION RESEARCH (2010)
Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1α/Mitofusin-2 Regulatory Pathway in Response to Physical Activity
Maria Isabel Hernandez-Alvarez et al.
DIABETES CARE (2010)
Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α) and Sirtuin 1 (SIRT1) Reside in Mitochondria POSSIBLE DIRECT FUNCTION IN MITOCHONDRIAL BIOGENESIS
Katia Aquilano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
NAD+, Sirtuins, and Cardiovascular Disease
Nica M. Borradaile et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
RESVERATROL PRETREATMENT PROTECTS RAT BRAIN FROM CEREBRAL ISCHEMIC DAMAGE VIA A SIRTUIN 1-UNCOUPLING PROTEIN 2 PATHWAY
D. Della-Morte et al.
NEUROSCIENCE (2009)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Pharmacological activity of sanchi ginseng (Panax notoginseng)
T. B. Ng
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
BN Finck et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
LM Zhou et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α
S Nemoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle
S Terada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
WW Winder et al.
JOURNAL OF APPLIED PHYSIOLOGY (2000)